Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 4/20 | 0.46 |
| ▸ | CES1 | P23141 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.42 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3385461 | 0.83 | ELANE (0.54) | ELANECES2CES1TSHRLMNA | |
| SCHEMBL5485329 | 0.82 | LMNA (0.46) | CES2CES1TSHRLMNAMAPT | |
| SCHEMBL14775162 | 0.82 | LMNA (0.46) | CES2CES1TSHRLMNAMAPT | |
| SCHEMBL214249 | 0.81 | LMNA (0.42) | CES2CES1TSHRLMNAMAPT | |
| SCHEMBL3382989 | 0.81 | ALDH1A1 (0.48) | CES2CES1LMNAMAPTATM | |
| SCHEMBL382312 | 0.80 | LMNA (0.56) | CES2CES1TSHRLMNAMAPT | |
| SCHEMBL23534041 | 0.79 | TSHR (0.52) | CES2CES1TSHRLMNAMAPT | |
| SCHEMBL10812335 | 0.79 | NAPRT (0.45) | LMNASMN1; SMN2NPSR1ALDH1A1CYP3A4 | |
| SCHEMBL2221348 | 0.79 | ELANE (0.51) | ELANECES2CES1TSHRLMNA | |
| SCHEMBL8760128 | 0.79 | CES2 (0.46) | CES2CES1TSHRLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 707 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | claimed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | claimed |
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-12209232-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-28 | — | — | US | claimed |
| EP-4377427-A1 | IMPROVED PERFUME COMPOSITIONS COMPRISING SULFUR-CONTAINING PRO-FRAGRANCE COMPOUNDS | Firmenich SA (CH) | 2024-06-05 | — | — | EP | claimed |
| CN-118019834-A | Improved perfume compositions comprising sulfur-containing fragrance precursor compounds | 弗门尼舍有限公司 | 2024-05-10 | — | — | CN | claimed |
| WO-2023247599-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| US-20230340375-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2023-10-26 | — | — | US | claimed |
| US-7129206-B2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2006-10-31 | — | — | US | claimed |
| US-20030144173-A1 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-31 | — | — | US | claimed |
| EP-1329497-A2 | Utilization of unsaturated esters as perfuming ingredients | FIRMENICH SA (CH) | 2003-07-23 | — | — | EP | claimed |
| EP-0568993-B1 | Chemical amplification resist composition | KYOWA HAKKO KOGYO KK (JP) | 1998-08-12 | — | — | EP | claimed |
| EP-0537879-B1 | Aryl triflate compound, radiologically acid producing agent, radiologically acid producing agent system, and radiosensitive composition | HITACHI CHEMICAL CO LTD (JP) | 1998-04-29 | — | — | EP | claimed |
| EP-0592552-B1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES | DU PONT (US) | 1997-05-28 | — | — | EP | claimed |
| US-5559267-A | ENANTIOMORPHS, STEREOCHEMICAL CONTROL AND ASSYMETRIC INDUCTION, HYDROGENATION OF UNSATURATED ESTERS, COORDINATION CATALYSTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-09-24 | — | — | US | claimed |
| US-5527659-A | PHOTOSENSITIVITY | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1996-06-18 | — | — | US | claimed |
| EP-0592552-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES. | DU PONT (US) | 1994-04-20 | — | — | EP | claimed |
| WO-1993001199-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-01-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144173-A1 | Utilization of unsaturated esters as perfuming ingredients | CPT1A, FASN, FFAR3 | ELANE 3207/4885CES2 1087/4885CES1 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.